98 related articles for article (PubMed ID: 15727605)
1. Predictors of a positive baseline bone scan in breast cancer.
Ho YY; Chan YH
Australas Radiol; 2005 Feb; 49(1):21-6. PubMed ID: 15727605
[TBL] [Abstract][Full Text] [Related]
2. Comparing whole body (18)F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphonate bone scan to detect bone metastases in patients with breast cancer.
Yang SN; Liang JA; Lin FJ; Kao CH; Lin CC; Lee CC
J Cancer Res Clin Oncol; 2002 Jun; 128(6):325-8. PubMed ID: 12073051
[TBL] [Abstract][Full Text] [Related]
3. 99mTc-antigranulocyte bone marrow scintigraphy of breast and prostate skeletal metastases.
Limouris GS; Voliotopoulos V; Stavraka A; Vlahos L
Anticancer Res; 1997; 17(3B):1615-8. PubMed ID: 9179204
[TBL] [Abstract][Full Text] [Related]
4. Relation between pain and skeletal metastasis in patients with prostate or breast cancer.
Levren G; Sadik M; Gjertsson P; Lomsky M; Michanek A; Edenbrandt L
Clin Physiol Funct Imaging; 2011 May; 31(3):193-5. PubMed ID: 21114613
[TBL] [Abstract][Full Text] [Related]
5. [Indication for bone scans in early breast cancer staging].
de la Cueva L; Liévano P; Navarro P; Arroyo E; Añaños M; González M; García MC; Fuerte A; Colmenarejo F; Baringo T; Abós MD
Rev Esp Med Nucl; 2009; 28(6):273-7. PubMed ID: 19995533
[TBL] [Abstract][Full Text] [Related]
6. Reappraisal of the baseline bone scan in breast cancer.
Coleman RE; Rubens RD; Fogelman I
J Nucl Med; 1988 Jun; 29(6):1045-9. PubMed ID: 3373314
[TBL] [Abstract][Full Text] [Related]
7. Radionuclide bone scan in initial staging of breast cancer.
Boughattas S; Hassine H; Chatti K; Essabbah H
Tunis Med; 2003 Mar; 81(3):156-61. PubMed ID: 12793064
[TBL] [Abstract][Full Text] [Related]
8. Bone metastases are infrequent in patients with newly diagnosed prostate cancer: analysis of their clinical and pathologic features.
Salonia A; Gallina A; Camerota TC; Picchio M; Freschi M; DaPozzo LF; Guazzoni G; Fazio F; Rigatti P; Montorsi F
Urology; 2006 Aug; 68(2):362-6. PubMed ID: 16904453
[TBL] [Abstract][Full Text] [Related]
9. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
Alam MS; Takeuchi R; Kasagi K; Misaki T; Miyamoto S; Iida Y; Hidaka A; Konishi J
Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573
[TBL] [Abstract][Full Text] [Related]
10. Predictors of Positive Bone Metastasis in Newly Diagnosed Prostate Cancer Patients.
Chien TM; Lu YM; Geng JH; Huang TY; Ke HL; Huang CN; Li CC; Chou YH; Wu WJ; Huang SP
Asian Pac J Cancer Prev; 2016; 17(3):1187-91. PubMed ID: 27039746
[TBL] [Abstract][Full Text] [Related]
11. Bone scintigraphy and the added value of SPECT (single photon emission tomography) in detecting skeletal lesions.
Savelli G; Maffioli L; Maccauro M; De Deckere E; Bombardieri E
Q J Nucl Med; 2001 Mar; 45(1):27-37. PubMed ID: 11456373
[TBL] [Abstract][Full Text] [Related]
12. Comparison and discrepancy of 18F-2-deoxyglucose positron emission tomography and Tc-99m MDP bone scan to detect bone metastases.
Kao CH; Hsieh JF; Tsai SC; Ho YJ; Yen RF
Anticancer Res; 2000; 20(3B):2189-92. PubMed ID: 10928175
[TBL] [Abstract][Full Text] [Related]
13. Is bone scanning of value in patients with breast cancer?
Spencer GR; Khan M; Bird C; Seymour R; Brown TR; Collins CD
Acta Chir Scand; 1981; 147(4):247-8. PubMed ID: 6459704
[TBL] [Abstract][Full Text] [Related]
14. A reassessment of bone scintigraphy and commonly tested pretreatment biochemical parameters in newly diagnosed osteosarcoma.
Stokkel MP; Linthorst MF; Borm JJ; Taminiau AH; Pauwels EK
J Cancer Res Clin Oncol; 2002 Jul; 128(7):393-9. PubMed ID: 12136254
[TBL] [Abstract][Full Text] [Related]
15. Technetium-99m MDP scintigraphy. An insensitive tool for the detection of bone marrow metastases.
Gulenchyn KY; Papoff W
Clin Nucl Med; 1987 Jan; 12(1):45-6. PubMed ID: 3815996
[TBL] [Abstract][Full Text] [Related]
16. Improved classifications of planar whole-body bone scans using a computer-assisted diagnosis system: a multicenter, multiple-reader, multiple-case study.
Sadik M; Suurkula M; Höglund P; Järund A; Edenbrandt L
J Nucl Med; 2009 Mar; 50(3):368-75. PubMed ID: 19223423
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow immunoscintigraphy for the detection of skeletal metastases in patients with breast cancer.
Lacić M; Bokulić T; Lukac J; Kovacić K; Baum RP; Kusić Z
Nucl Med Commun; 1999 Feb; 20(2):135-43. PubMed ID: 10088162
[TBL] [Abstract][Full Text] [Related]
18. Planar Bone Scan Versus Computerized Tomography in Staging Locally Advanced Breast Cancer in Asymptomatic Patients: Does Bone Scan Change Patient Management Over Computerized Tomography?
Bansal GJ; Vinayan Changaradil D
J Comput Assist Tomogr; 2018; 42(1):19-24. PubMed ID: 28786907
[TBL] [Abstract][Full Text] [Related]
19. Skeletal scintigraphy in carcinoma of the breast--a ten year retrospective study of 389 patients.
Ahmed A; Glynne-Jones R; Ell PJ
Nucl Med Commun; 1990 Jun; 11(6):421-6. PubMed ID: 2385428
[TBL] [Abstract][Full Text] [Related]
20. Bone scintigraphy in the monitoring of treatment effect of bisphosphonates in bone metastatic breast cancer.
Chavdarova L; Piperkova E; Tsonevska A; Timcheva K; Dimitrova M
J BUON; 2006; 11(4):499-504. PubMed ID: 17309184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
